- GBP/USD sold-into news that UK PM Johnson gets hospitalized.
- Coronavirus risks will continue to boost have flows for the USD.
- UK Construction PMI eyed amid a quiet macro day this Monday.
Amid reports that the UK Prime Minister (PM) Boris Johnson is admitted to hospital for some coronavirus-linked precautionary tests combined with persisting broad US dollar weakness, GBP/USD started out a fresh week on a negative note in Asia this Monday.
Coronavirus tightens grip over the UK
The cable remains the main laggard across the fx space so far, as the bears look to test the 0.2200 level, having eroded nearly 60-pips in early trades. The main catalyst behind the sharp drop is about the increased concerns over the PM Johnson’s health condition, as he gets hospitalized after dealing with mild virus symptoms for 10 days after being tested positive.
The Downing Street statement read, "On the advice of his doctor, the Prime Minister has tonight been admitted to hospital for tests. This is a precautionary step, as the Prime Minister continues to have persistent symptoms of coronavirus ten days after testing positive for the virus."
The recent chatter that the PM is put on the ventilator support is likely to aggravate the pain in the pound. Further, the ongoing strength in the US dollar vs. its six major rivals, in the wake of the increased safe-haven demand, as the pandemic intensifies worldwide and heightens the fears over a global economic recession, collaborates with the downside momentum in the spot, as the British currency gives up its last week’s resilience.
Meanwhile, on the data front, the greenback remained unperturbed by a 7 million drop in the US jobs for March, as the upbeat US ISM Non-Manufacturing PMI boded well for the buck. However, the UK Services PMI data for March was revised down to 34.5 points, which is likely to remain a drag on the sterling.
In the day ahead, the updates on the PM Johnson’s condition will remain a key driver for the major alongside the US dollar dynamics, as the macro calendar Is relatively quiet, with the only UK Construction PMI of note. Meanwhile, all eyes will be on the UK government COVID-19 meeting, scheduled at 0815GMT for fresh trading impetus. The meeting will be chaired by the UK Foreign Secretary Raab and include the advisers and officials.
Note that the latest data published by the UK's health ministry revealed that the death toll from the coronavirus increased by 621 to 4,934. The total number of confirmed infections climbed to 47,806.
GBP/USD technical levels to watch
|Today last price||1.2229|
|Today Daily Change||-0.0041|
|Today Daily Change %||-0.33|
|Today daily open||1.227|
|Previous Daily High||1.2408|
|Previous Daily Low||1.2205|
|Previous Weekly High||1.2476|
|Previous Weekly Low||1.2205|
|Previous Monthly High||1.3201|
|Previous Monthly Low||1.1412|
|Daily Fibonacci 38.2%||1.2283|
|Daily Fibonacci 61.8%||1.2331|
|Daily Pivot Point S1||1.2181|
|Daily Pivot Point S2||1.2092|
|Daily Pivot Point S3||1.1978|
|Daily Pivot Point R1||1.2384|
|Daily Pivot Point R2||1.2497|
|Daily Pivot Point R3||1.2587|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.